Cargando…
Molecular mechanisms regulating the hormone sensitivity of breast cancer
Breast cancer is a heterogeneous disease. Approximately 70% of breast cancers are estrogen receptor (ER) positive. Endocrine therapy has dramatically improved the prognosis of ER-positive breast cancer; however, many tumors exhibit de novo or acquired resistance to endocrine therapy. A thorough unde...
Autores principales: | Tokunaga, Eriko, Hisamatsu, Yuichi, Tanaka, Kimihiro, Yamashita, Nami, Saeki, Hiroshi, Oki, Eiji, Kitao, Hiroyuki, Maehara, Yoshihiko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4462367/ https://www.ncbi.nlm.nih.gov/pubmed/25155268 http://dx.doi.org/10.1111/cas.12521 |
Ejemplares similares
-
Expression of APOBEC3B mRNA in Primary Breast Cancer of Japanese Women
por: Tokunaga, Eriko, et al.
Publicado: (2016) -
Differential impact of the expression of the androgen receptor by age in estrogen receptor–positive breast cancer
por: Tokunaga, Eriko, et al.
Publicado: (2013) -
The early discontinuation of adjuvant hormone therapy is associated with a poor prognosis in Japanese breast cancer patients
por: Taketani, Kenji, et al.
Publicado: (2013) -
DNA replication stress and cancer chemotherapy
por: Kitao, Hiroyuki, et al.
Publicado: (2017) -
Contribution of BubR1 to oxidative stress-induced aneuploidy in p53-deficient cells
por: Ikawa-Yoshida, Ayae, et al.
Publicado: (2013)